Bifidobacterium and Enteral Feeding in Preterm Infants: Cluster-randomized Trial

Overview

Journal Pediatr Int

Specialty Pediatrics

Date 2014 Mar 13

PMID 24617812

Citations 44

Authors

Satsuki Totsu

Chika Yamasaki

Masaki Terahara

Atsushi Uchiyama

Satoshi Kusuda

Affiliations

Soon will be listed here.

Abstract

Background: This study evaluated the benefit of Bifidobacterium bifidum OLB6378 (B. bifidum) in very low-birthweight (VLBW) infants (birthweight <1500 g) for the acceleration of enteral feeding.

Methods: A cluster-randomized, double-blind, placebo-controlled trial was conducted in 19 hospitals, divided into two groups: the B group (n = 10 hospitals; B. bifidum given to infants within 48 h of birth) and the P group (n = 9 hospitals; infants received a placebo). The primary outcome was establishment of enteral feeding after birth, defined as the postnatal day at which enteral feeding exceeded 100 mL/(kg/day). Secondary outcomes were defined as incidence of morbidity and somatic growth before discharge.

Results: Overall, 283 VLBW infants were enrolled in the study: B group, n = 153; and P group, n = 130. Enteral feeding was established within 21 days after birth in 233 infants, of whom 119 received B. bifidum and 114 received placebo until their bodyweight reached 2000 g. Enteral feeding was established significantly earlier in the B group, at 11.0 ± 3.6 days versus 12.1 ± 3.8 days in P group (P < 0.05). Infant growth during the stay in the neonatal intensive care unit was not different between groups, but the incidence of late-onset sepsis among all enrolled infants was significantly lower in the B group (3.9%, 6/153) than in the P group (10.0%, 13/130; P < 0.05). No differences were observed in the incidence of other adverse outcomes including mortality.

Conclusions: B. bifidum in VLBW infants accelerated the establishment of enteral feeding after birth without increasing the incidence of adverse effects.

Citing Articles

Construction and SHAP interpretability analysis of a risk prediction model for feeding intolerance in preterm newborns based on machine learning.

Xu H, Peng X, Peng Z, Wang R, Zhou R, Fu L BMC Med Inform Decis Mak. 2024; 24(1):342.

PMID: 39558307 PMC: 11572196. DOI: 10.1186/s12911-024-02751-5.

Gut microbial network signatures of early colonizers in preterm neonates with extrauterine growth restriction.

Liang Y, Yao X, Meng Z, Lan J, Qiu Y, Cen C BMC Microbiol. 2024; 24(1):82.

PMID: 38461289 PMC: 10924324. DOI: 10.1186/s12866-024-03234-3.

Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.

Sharif S, Meader N, Oddie S, Rojas-Reyes M, McGuire W Cochrane Database Syst Rev. 2023; 7:CD005496.

PMID: 37493095 PMC: 10370900. DOI: 10.1002/14651858.CD005496.pub6.

Effects of neonatal nutrition interventions on neonatal mortality and child health and development outcomes: A systematic review.

Imdad A, Rehman F, Davis E, Ranjit D, Surin G, Attia S Campbell Syst Rev. 2023; 17(1):e1141.

PMID: 37133295 PMC: 8356300. DOI: 10.1002/cl2.1141.

Current and future methods of probiotic therapy for necrotizing enterocolitis.

Sajankila N, Wala S, Ragan M, Volpe S, Dumbauld Z, Purayil N Front Pediatr. 2023; 11():1120459.

PMID: 36937955 PMC: 10017871. DOI: 10.3389/fped.2023.1120459.

References

Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T . Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011; (3):CD005496. DOI: 10.1002/14651858.CD005496.pub3. View

Kusuda S, Fujimura M, Sakuma I, Aotani H, Kabe K, Itani Y . Morbidity and mortality of infants with very low birth weight in Japan: center variation. Pediatrics. 2006; 118(4):e1130-8. DOI: 10.1542/peds.2005-2724. View

Cilieborg M, Boye M, Sangild P . Bacterial colonization and gut development in preterm neonates. Early Hum Dev. 2012; 88 Suppl 1:S41-9. DOI: 10.1016/j.earlhumdev.2011.12.027. View

Khailova L, Mount Patrick S, Arganbright K, Halpern M, Kinouchi T, Dvorak B . Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2010; 299(5):G1118-27. PMC: 2993641. DOI: 10.1152/ajpgi.00131.2010. View

Wan A, Seow W, Purdie D, Bird P, Walsh L, Tudehope D . Immunoglobulins in saliva of preterm and full-term infants. Oral Microbiol Immunol. 2003; 18(2):72-8. DOI: 10.1034/j.1399-302x.2003.00044.x. View

Westerbeek E, van den Berg A, Lafeber H, Knol J, Fetter W, van Elburg R . The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr. 2006; 25(3):361-8. DOI: 10.1016/j.clnu.2006.03.002. View

Kusuda S, Fujimura M, Uchiyama A, Totsu S, Matsunami K . Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan. Pediatr Res. 2012; 72(5):531-8. PMC: 3547175. DOI: 10.1038/pr.2012.114. View

Stratiki Z, Costalos C, Sevastiadou S, Kastanidou O, Skouroliakou M, Giakoumatou A . The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev. 2007; 83(9):575-9. DOI: 10.1016/j.earlhumdev.2006.12.002. View

Underwood M, Salzman N, Bennett S, Barman M, Mills D, Marcobal A . A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr. 2009; 48(2):216-25. PMC: 2743418. DOI: 10.1097/MPG.0b013e31818de195. View

10.

Sherman M . New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin Perinatol. 2010; 37(3):565-79. PMC: 2933426. DOI: 10.1016/j.clp.2010.05.006. View

11.

Khailova L, Dvorak K, Arganbright K, Halpern M, Kinouchi T, Yajima M . Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2010; 297(5):G940-9. PMC: 2777452. DOI: 10.1152/ajpgi.00141.2009. View

12.

Yamasaki C, Totsu S, Uchiyama A, Nakanishi H, Masumoto K, Washio Y . Effect of Bifidobacterium administration on very-low-birthweight infants. Pediatr Int. 2012; 54(5):651-6. DOI: 10.1111/j.1442-200X.2012.03649.x. View

13.

Lee S, Cho S, Park E . Effects of probiotics on enteric flora and feeding tolerance in preterm infants. Neonatology. 2007; 91(3):174-9. DOI: 10.1159/000097449. View

14.

Campeotto F, Suau A, Kapel N, Magne F, Viallon V, Ferraris L . A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br J Nutr. 2011; 105(12):1843-51. DOI: 10.1017/S0007114510005702. View

15.

Fujii T, Ohtsuka Y, Lee T, Kudo T, Shoji H, Sato H . Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr. 2006; 43(1):83-8. DOI: 10.1097/01.mpg.0000228100.04702.f8. View

16.

Hayes J, Adamson-Macedo E, Perera S, Anderson J . Detection of secretory immunoglobulin A (SIgA) in saliva of ventilated and non-ventilated preterm neonates. Neuro Endocrinol Lett. 2001; 20(1-2):109-113. View

17.

Al-Hosni M, Duenas M, Hawk M, Stewart L, Borghese R, Cahoon M . Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol. 2011; 32(4):253-9. DOI: 10.1038/jp.2011.51. View

18.

Leaf A, Dorling J, Kempley S, McCormick K, Mannix P, Linsell L . Early or delayed enteral feeding for preterm growth-restricted infants: a randomized trial. Pediatrics. 2012; 129(5):e1260-8. DOI: 10.1542/peds.2011-2379. View

19.

Mohan R, Koebnick C, Schildt J, Mueller M, Radke M, Blaut M . Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res. 2008; 64(4):418-22. DOI: 10.1203/PDR.0b013e318181b7fa. View

20.

Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C . Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001; 121(3):580-91. DOI: 10.1053/gast.2001.27224. View